322 related articles for article (PubMed ID: 18417984)
1. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
Sharony R; Itzhaky D; Amiel A; Hershko A; Grinshpoon Y; Fejgin M
Fetal Diagn Ther; 2008; 23(3):233-6. PubMed ID: 18417984
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
3. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
4. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
[TBL] [Abstract][Full Text] [Related]
5. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
Tavor O; Shohat M; Lipitz S
Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
7. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy.
Walton DL; Norem CT; Schoen EJ; Ray GT; Colby CJ
N Engl J Med; 1999 Dec; 341(27):2033-8. PubMed ID: 10615074
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
Pahal GS; Jauniaux E
Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582
[TBL] [Abstract][Full Text] [Related]
9. Effect of fetal gender on maternal serum human chorionic gonadotropin levels throughout pregnancy.
Gol M; Guclu S; Demir A; Erata Y; Demir N
Arch Gynecol Obstet; 2005 Dec; 273(2):90-2. PubMed ID: 15991013
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications.
Sharony R; Zipper O; Amichay K; Wiser A; Kidron D; Biron-Shental T; Maymon R
J Obstet Gynaecol; 2017 Jul; 37(5):576-579. PubMed ID: 28604182
[TBL] [Abstract][Full Text] [Related]
11. Complete hydatidiform mole coexisting with a live fetus after gamete intrafallopian transfer. A case report.
Manase K; Henmi H; Yamanaka I; Endo T; Hayakawa O; Kudo R
J Reprod Med; 2000 Mar; 45(3):227-30. PubMed ID: 10756502
[TBL] [Abstract][Full Text] [Related]
12. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
[TBL] [Abstract][Full Text] [Related]
14. Androgenetic complete mole coexistent with a twin live fetus.
Matsui H; Iitsuka Y; Ishii J; Osada H; Seki K; Sekiya S
Gynecol Oncol; 1999 Aug; 74(2):217-21. PubMed ID: 10419734
[TBL] [Abstract][Full Text] [Related]
15. Fetal growth in patients with elevated maternal serum hCG levels.
Tanaka M; Natori M; Kohno H; Ishimoto H; Kobayashi T; Nozawa S
Obstet Gynecol; 1993 Mar; 81(3):341-3. PubMed ID: 8437782
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
[TBL] [Abstract][Full Text] [Related]
17. Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG).
Santolaya-Forgas J; Meyer WJ; Burton BK; Scommegna A
J Matern Fetal Med; 1997; 6(2):111-4. PubMed ID: 9086428
[TBL] [Abstract][Full Text] [Related]
18. Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction.
Towner DR; Shaffer LG; Yang SP; Walgenbach DD
Prenat Diagn; 2001 May; 21(5):395-8. PubMed ID: 11360282
[TBL] [Abstract][Full Text] [Related]
19. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
Cowans NJ; Spencer K; Meiri H
Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
[TBL] [Abstract][Full Text] [Related]
20. Elevated human chorionic gonadotropin levels in pregnancies with sex chromosome abnormalities.
Barnes-Kedar I; Amiel A; Maor O; Fejgin M
Am J Med Genet; 1993 Feb; 45(3):356-7. PubMed ID: 8434623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
